These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 24697357)

  • 21. Myeloid mixed chimerism is associated with relapse in bcr-abl positive patients after unmanipulated allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Román J; Serrano J; Jiménez A; Castillejo JA; Reina ML; González MG; Rodríguez MC; García I; Sánchez J; Maldonado J; Torres A
    Haematologica; 2000 Feb; 85(2):173-80. PubMed ID: 10681725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Haploidentical family member transplants for patients with chronic myeloid leukaemia: a report of the Chronic Leukaemia Working Party of off European Group for Blood and Marrow Transplantation (EBMT).
    Speiser DE; Hermans J; van Biezen A; Starobinski M; Jeannet M; Jacobsen N; Niederwieser D; Gratwohl A; Apperley JF
    Bone Marrow Transplant; 1997 Jun; 19(12):1197-203. PubMed ID: 9208113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic myeloid leukemia after living donor liver transplantation.
    Concejero A; Chen CL; Wang CC; Wang SH; Lin CC; Liu YW; Yang CH; Yong CC; Wang MC; Eng HL
    Transplantation; 2007 Jun; 83(11):1521-2. PubMed ID: 17565329
    [No Abstract]   [Full Text] [Related]  

  • 24. [Allogeneic hematopoietic stem cell transplantation in chronic myeloid leukemia].
    Tomás JF; Fernández-Rañada JM
    Sangre (Barc); 1998 Apr; 43(2):147-54. PubMed ID: 9656776
    [No Abstract]   [Full Text] [Related]  

  • 25. Sign of the Zodiac as a predictor of survival for recipients of an allogeneic stem cell transplant for chronic myeloid leukaemia (CML): an artificial association.
    Szydlo RM; Gabriel I; Olavarria E; Apperley J
    Transplant Proc; 2010 Oct; 42(8):3312-5. PubMed ID: 20970679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular analysis of transient cytogenetic relapse after allogeneic bone marrow transplantation for chronic myeloid leukaemia.
    Lin F; Kirkland MA; van Rhee FV; Chase A; Coulthard S; Bungey J; Goldman JM; Cross NC
    Bone Marrow Transplant; 1996 Dec; 18(6):1147-52. PubMed ID: 8971386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic Myeloid Leukaemia in The 21st Century.
    Frazer R; Irvine AE; McMullin MF
    Ulster Med J; 2007 Jan; 76(1):8-17. PubMed ID: 17288299
    [No Abstract]   [Full Text] [Related]  

  • 28. Low incidence of neoplasia in heart and heart-lung transplant recipients receiving triple-drug immunosuppression.
    Olivari MT; Diekmann RA; Kubo SH; Braunlin E; Jamieson SW; Ring WS
    J Heart Transplant; 1990; 9(6):618-21. PubMed ID: 2277297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Post-transplant outcome in chronic myeloid leukaemia.
    Raza S; Ullah K; Ahmed P; Khan B; Kamal MK
    J Coll Physicians Surg Pak; 2008 Oct; 18(10):615-9. PubMed ID: 18940118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intensification of the conditioning regimen by the addition of anthracyclines results in a higher incidence of sustained molecular remissions after allogeneic bone marrow transplantation for chronic myeloid leukaemia with marrow depleted of lymphocytes by counterflow centrifugation.
    Schattenberg A; Mensink E; de Witte T
    Cas Lek Cesk; 1996 Apr; 135(8):239-43. PubMed ID: 8689662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistent donor chimaerism is consistent with disease-free survival following BMT for chronic myeloid leukaemia.
    Gardiner N; Lawler M; O'Riordan J; DeArce M; Humphries P; McCann SR
    Bone Marrow Transplant; 1997 Aug; 20(3):235-41. PubMed ID: 9257892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia].
    González FA; Villegas A; Ferro MT; San Román C; Sáez I; López M; del Potro E; Alvarez A; Martínez R; Díaz Madiavilla J
    Med Clin (Barc); 1993 Oct; 101(14):521-4. PubMed ID: 8231395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Appearance of a chronic myeloid leukemia in Waldenström's macroglobulinemia].
    Majado MJ; González García C; Marín-Blazquez MD; Morales Lázaro A; Moreno Moreno M
    Sangre (Barc); 1992 Dec; 37(6):465-6. PubMed ID: 1293799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urological malignancy after renal transplantation.
    Besarani D; Cranston D
    BJU Int; 2007 Sep; 100(3):502-5. PubMed ID: 17669141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unrelated donor peripheral blood stem cell transplants incorporating pre-transplant in-vivo alemtuzumab are not associated with any increased risk of significant acute or chronic graft-versus-host disease.
    Shaw BE; Apperley JF; Russell NH; Craddock C; Liakopoulou E; Potter MN; Wynn R; Gibson B; Pearce RM; Kirkland K; Lee J; Madrigal JA; Cook G; Byrne JL
    Br J Haematol; 2011 Apr; 153(2):244-52. PubMed ID: 21382020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific point mutations that activate v-abl are not found in Philadelphia-negative chronic myeloid leukaemia, Philadelphia-negative acute lymphoblastic leukaemia or blast transformation of chronic myeloid leukaemia.
    Melo JV; Goldman JM
    Leukemia; 1992 Aug; 6(8):786-90. PubMed ID: 1353550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting primary human leukaemia cells with RNA interference: Bcr-Abl targeting inhibits myeloid progenitor self-renewal in chronic myeloid leukaemia cells.
    Withey JM; Marley SB; Kaeda J; Harvey AJ; Crompton MR; Gordon MY
    Br J Haematol; 2005 May; 129(3):377-80. PubMed ID: 15842662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute myeloid leukemia following solid organ transplantation: case report and comprehensive review.
    Kourelis TV; Boruchov A; Hull D; Polio J; Scholes J; Moustakakis M; Bilgrami SF
    Conn Med; 2012 Mar; 76(3):151-4. PubMed ID: 22666974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapse.
    Apperley JF; Jones L; Hale G; Waldmann H; Hows J; Rombos Y; Tsatalas C; Marcus RE; Goolden AW; Gordon-Smith EC
    Bone Marrow Transplant; 1986 May; 1(1):53-66. PubMed ID: 3332120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No advantage for patients who receive splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia: results of a prospective randomized study.
    Gratwohl A; Hermans J; von Biezen A; Arcese W; de Witte T; Debusscher L; Ernst P; Ferrant A; Frassoni F; Gahrton G
    Bone Marrow Transplant; 1992 Aug; 10(2):147-52. PubMed ID: 1525604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.